Bristol-Myers Recalls Cancer Drug

9/11/2012 1:00 PM EST

More than 31,000 units of a chemotherapy drug were recalled by Bristol-Myers Squibb Co. after the discovery of an overfilled vial raised patient overdose concerns.

According to a USA Today report, 10 lots of BiCNU, an injection of the drug carmustine, have been affected by the recall. The drug is used in chemotherapy to treat cancers such as brain tumors, multiple myeloma, Hodgkin's disease, and non-Hodgkin's lymphoma.

The drug was recalled due to the fear of a patient overdose, which may result in serious injuries such as lung or kidney toxicity. No cases of adverse effects have been reported as yet.

The recall was issued for drug vials sold in the U.S., Canada, Europe, Latin America, and Asia.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law today for a free legal consultation and to find out if a dangerous drugs lawyer may be able to able to help you.